Patents by Inventor Michael S. Kay

Michael S. Kay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11020482
    Abstract: Disclosed herein are compositions and methods for inhibiting viral entry.
    Type: Grant
    Filed: August 21, 2019
    Date of Patent: June 1, 2021
    Assignee: THE UNIVERSITY OF UTAH RESEARCH FOUNDATION
    Inventors: J. Nicholas Francis, Joseph S. Redman, Michael S. Kay
  • Patent number: 10765754
    Abstract: Disclosed herein are compositions and methods for inhibiting respiratory syncytial virus (RSV) entry into a host cell. Also provided herein are methods of identifying a peptide that interacts with the N-trimer of RSV F protein.
    Type: Grant
    Filed: August 26, 2016
    Date of Patent: September 8, 2020
    Assignees: Navigen, Inc., University of Utah Research Foundation
    Inventors: Brett D. Welch, Michael S. Kay, Debra Muir Eckert, Rena McKinnon, Michael Thomas Jacobsen
  • Publication number: 20200215191
    Abstract: Disclosed herein are compositions and methods for inhibiting viral entry.
    Type: Application
    Filed: August 21, 2019
    Publication date: July 9, 2020
    Inventors: J. Nicholas FRANCIS, Joseph S. REDMAN, Michael S. Kay
  • Patent number: 10512665
    Abstract: Disclosed are compositions and methods for inhibiting viral entry.
    Type: Grant
    Filed: June 2, 2016
    Date of Patent: December 24, 2019
    Assignee: UNIVERSITY OF UTAH RESEARCH FOUNDATION
    Inventors: Michael S. Kay, Brett D. Welch
  • Patent number: 10487121
    Abstract: Disclosed are D-peptide compositions and methods for inhibiting HIV entry into host cells.
    Type: Grant
    Filed: January 6, 2017
    Date of Patent: November 26, 2019
    Assignees: Navigen, Inc., University of Utah Research Foundation
    Inventors: Brett D. Welch, James Nicholas Francis, Michael S. Kay
  • Patent number: 10406229
    Abstract: Disclosed herein are compositions and methods for inhibiting viral entry.
    Type: Grant
    Filed: March 2, 2017
    Date of Patent: September 10, 2019
    Assignee: UNIVERSITY OF UTAH RESEARCH FOUNDATION
    Inventors: J. Nicholas Francis, Joseph S. Redman, Michael S. Kay
  • Patent number: 10189878
    Abstract: Ebolavirus is a highly lethal filovirus that causes hemorrhagic fever in humans and non-human primates. With no approved treatments or preventatives, the development of an anti-ebolavirus therapy to protect against natural infections and potential weaponization is an urgent unmet global health need. The design, biophysical characterization, and validation of peptide mimics of the ebolavirus N-trimer (“N-trimer mimics”) are described herein.
    Type: Grant
    Filed: September 24, 2015
    Date of Patent: January 29, 2019
    Assignees: University of Utah Research Foundation, Navigen, Inc., The United States of America—Air Force
    Inventors: Tracy R. Clinton, Michael Thomas Jacobsen, Matthew T. Weinstock, Brett D. Welch, Debra Muir Eckert, Michael S. Kay
  • Publication number: 20190023748
    Abstract: Disclosed are D-peptide compositions and methods for inhibiting HIV entry into host cells.
    Type: Application
    Filed: January 6, 2017
    Publication date: January 24, 2019
    Inventors: Brett D. WELCH, James Nicholas FRANCIS, Michael S. KAY
  • Publication number: 20180280520
    Abstract: Disclosed herein are compositions and methods for inhibiting respiratory syncytial virus (RSV) entry into a host cell. Also provided herein are methods of identifying a peptide that interacts with the N-trimer of RSV F protein.
    Type: Application
    Filed: August 26, 2016
    Publication date: October 4, 2018
    Inventors: BRETT D. WELCH, MICHAEL S. KAY, DEBRA MUIR ECKERT, RENA MCKINNON, MICHAEL THOMAS JACOBSEN
  • Publication number: 20170247418
    Abstract: Ebolavirus is a highly lethal filovirus that causes hemorrhagic fever in humans and non-human primates. With no approved treatments or preventatives, the development of an anti-ebolavirus therapy to protect against natural infections and potential weaponization is an urgent unmet global health need. The design, biophysical characterization, and validation of peptide mimics of the ebolavirus N-trimer (“N-trimer mimics”) are described herein.
    Type: Application
    Filed: September 24, 2015
    Publication date: August 31, 2017
    Inventors: Tracy R. CLINTON, Michael Thomas JACOBSEN, Matthew T. WEINSTOCK, Brett D. WELCH, Debra Muir ECKERT, Michael S. KAY
  • Publication number: 20170239364
    Abstract: Disclosed herein are compositions and methods for inhibiting viral entry.
    Type: Application
    Filed: March 2, 2017
    Publication date: August 24, 2017
    Inventors: J. Nicholas FRANCIS, Joseph S. REDMAN, Michael S. Kay
  • Publication number: 20160354428
    Abstract: Disclosed are compositions and methods for inhibiting viral entry.
    Type: Application
    Filed: June 2, 2016
    Publication date: December 8, 2016
    Inventors: Michael S. Kay, Brett D. Welch
  • Patent number: 9381226
    Abstract: Disclosed are compositions and methods for inhibiting viral entry.
    Type: Grant
    Filed: February 8, 2008
    Date of Patent: July 5, 2016
    Assignee: UNIVERSITY OF UTAH RESEARCH FOUNDATION
    Inventors: Michael S. Kay, Brett D. Welch
  • Publication number: 20140323392
    Abstract: Disclosed herein are compositions and methods for inhibiting viral entry.
    Type: Application
    Filed: March 28, 2012
    Publication date: October 30, 2014
    Applicant: UNIVERSITY OF UTAH RESEARCH FOUNDATION
    Inventors: J. Nicholas Francis, Joseph S. Redman, Michael S. Kay
  • Patent number: 8058012
    Abstract: Five-Helix protein, which comprises the three N-helices and at least two, but not three, of the three C-helices of the trimer-of-hairpin structure of HIV gp41, separated by linkers, such as amino acid residue linkers, is disclosed. Six-Helix protein, which includes the three N-helices and the three C-helices of the trimer-of-hairpin structure of HIV gp41, separated by linkers, is also disclosed.
    Type: Grant
    Filed: January 20, 2009
    Date of Patent: November 15, 2011
    Assignee: Whitehead Institute For Biomedical Research
    Inventors: Michael J. Root, Michael S. Kay, David C. Chan, Peter S. Kim
  • Publication number: 20100196397
    Abstract: Five-Helix protein, which comprises the three N-helices and at least two, but not three, of the three C-helices of the trimer-of-hairpin structure of HIV gp41, separated by linkers, such as amino acid residue linkers, is disclosed. Six-Helix protein, which includes the three N-helices and the three C-helices of the trimer-of-hairpin structure of HIV gp41, separated by linkers, is also disclosed.
    Type: Application
    Filed: January 20, 2009
    Publication date: August 5, 2010
    Applicant: Whitehead Instutite for Biomedical Research
    Inventors: Michael J. Root, Michael S. Kay, David C. Chan, Peter S. Kim
  • Publication number: 20100184663
    Abstract: Disclosed are compositions and methods for inhibiting viral entry.
    Type: Application
    Filed: February 8, 2008
    Publication date: July 22, 2010
    Inventors: Michael S. Kay, Brett D. Welch
  • Patent number: 7504224
    Abstract: Five-Helix protein, which comprises the three N-helices and at least two, but not three, of the three C-helices of the trimer-of-hairpin structure of HIV gp41, separated by linkers, such as amino acid residue linkers, is disclosed. Six-Helix protein, which includes the three N-helices and the three C-helices of the trimer-of-hairpin structure of HIV gp41, separated by linkers, is also disclosed.
    Type: Grant
    Filed: June 13, 2005
    Date of Patent: March 17, 2009
    Assignee: Whitehead Institute for Biomedical Research
    Inventors: Michael J. Root, Michael S. Kay, David C. Chan, Peter S. Kim
  • Patent number: 7053179
    Abstract: Five-Helix protein, which comprises the three N-helices and at least two, but not three, of the three C-helices of the trimer-of-hairpin structure of HIV gp41, separated by linkers, such as amino acid residue linkers, is disclosed. Six-Helix protein, which includes the three N-helices and the three C-helices of the trimer-of-hairpin structure of HIV gp41, separated by linkers, is also disclosed.
    Type: Grant
    Filed: December 15, 2000
    Date of Patent: May 30, 2006
    Assignee: Whitehead Institute for Biomedical Research
    Inventors: Michael J. Root, Michael S. Kay, David C. Chan, Peter S. Kim
  • Publication number: 20030082525
    Abstract: Five-Helix protein, which comprises the three N-helices and at least two, but not three, of the three C-helices of the trimer-of-hairpin structure of HIV gp41, separated by linkers, such as amino acid residue linkers, is disclosed. Six-Helix protein, which includes the three N-helices and the three C-helices of the trimer-of-hairpin structure of HIV gp41, separated by linkers, is also disclosed.
    Type: Application
    Filed: June 14, 2002
    Publication date: May 1, 2003
    Applicant: Whitehead Institute for Biomedical Research
    Inventors: Michael J. Root, Michael S. Kay, David C. Chan, Peter S. Kim